NVIGEN
Sunnyvale, US · Founded 2011 · 12 employees on LinkedIn
NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
Founders & leadership
NVIGEN was founded in 2011 by Aihua Fu.
Board
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2014
▶$1.1MraisedMar 2014 · 13 investors · BiotechnologyRule 506(b)
- Xiangdong JinExecutive Officer
- Guoliang YuDirector
- Aihua FuExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Mar 2014
- Incorporated
- Corporation, California, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $275.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $201.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does NVIGEN do?
- NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
- Who founded NVIGEN?
- NVIGEN was founded by Aihua Fu in 2011.
- How much funding has NVIGEN raised?
- NVIGEN has disclosed $1.1M raised across 1 round.
- Where is NVIGEN headquartered?
- NVIGEN is headquartered in Sunnyvale, US.